How many institutions held AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share in Q4 2023?

10 institutional investors reported AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share for Q4 2023. Use the holders table for investor-level position and value details.

Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD)

Q: What does CUSIP 00808Y406 represent in this 13F holders report?

CUSIP 00808Y406 is the security identifier for AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share used to aggregate holder disclosures.

CUSIP: 00808Y406

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class: Equity / Common Stock, $0.001 par value per share
Shares outstanding: 768,300
Total 13F shares: 51,941
Share change: +51,941
Total reported value: $113,749
Price per share: $2.19
Number of holders: 10
Value change: +$113,749
Number of buys: 10

Quarterly Holders Quick Answers

What is CUSIP 00808Y406?
CUSIP 00808Y406 identifies AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2024

Recent filing periods for CUSIP 00808Y406:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023

Top shareholders of AEMD - Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Sabrina Martucci Johnson	3/4/5	Director	— class O/S missing	33,642	$73,676	—	31 Mar 2022	3/4/5
Charles J. Fisher Jr.	3/4/5	Chief Executive Officer, Director	— class O/S missing	192,600	—	—	10 Feb 2022	3/4/5
Guy F. Cipriani	3/4/5	Sr. V.P., Chief Bus. Officer, Director	— class O/S missing	100,200	—	—	10 Feb 2022	3/4/5
James B. Frakes	3/4/5	CFO & Sr. VP ? Finance	— class O/S missing	100,200	—	—	10 Feb 2022	3/4/5
Steven P. Larosa	3/4/5	Chief Medical Officer	— class O/S missing	100,200	—	—	10 Feb 2022	3/4/5
Lee D. Arnold	3/4/5	Chief Scientific Officer	— class O/S missing	60,620	—	—	01 Feb 2023	3/4/5

Institutional Holders of Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) as of Q4 2023

As of 31 Dec 2023, Aethlon Medical, Inc. - Common Stock, $0.001 par value per share (AEMD) was held by 10 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 51,941 shares. The largest 10 holders included VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., GROUP ONE TRADING, L.P., Tower Research Capital LLC (TRC), OSAIC HOLDINGS, INC., WELLS FARGO & COMPANY/MN, MORGAN STANLEY, UBS Group AG, and BARTLETT & CO. WEALTH MANAGEMENT LLC. This page lists 10 institutional shareholders reporting positions in this security for the Q4 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2023 vs Q1 2025 Across Filers

Q1 2025 holders

Q4 2023 holders

Holder diff

-14

Investor	Q1 2025 Shares	Q4 2023 Shares	Share Diff	Share Chg %	Q1 2025 Value $	Q4 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.